EZH2 and hepatocellular carcinoma: The subsequent decrease in EZH2 levels significantly increased the levels of a number of anti-metastatic genes, including circ-ADD3, by reducing the level of H3K27me3 on their promoter regions, thus forming a regulatory circuit to inhibit HCC metastasis95.